Don D Sin
Don D Sin is an expert in Pulmonology at St. Paul's Hospital (Canada, Vancouver) (Canada). As of October 2026, ScienceLeadR ranks Don D Sin in the top 1% of experts worldwide for Hypersensitivity, Coronavirus Infections and Lung Diseases, Obstructive. Don D Sin has authored 834 publications, the most recent in 2026, and is an investigator in 19 clinical trials, 3 of them ongoing. SLR score: 3,186 (community average: 125). How the SLR is computed.
LeadR Profile
Pulmonology
Subspecialties: Critical Care - Genetics - Public Health
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 1996 - 2026
Number : 834
Citations
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| ACCEPT 3.0: Recalibrating ACute COPD Exacerbation Prediction Tool (ACCEPT) for global use. PMID 42850639 — pulmonary disease, chronic obstructive, therapeutics | Diagn Progn Res | 2026 | 0 |
| Statin as Regulatory T Cell Modulator in COPD With Early Disease. PMID 42852903 — cells, t-lymphocytes, regulatory, lung, smokers, pulmonary disease, chronic obstructive, therapeutics, hydroxymethylglutaryl-coa reductase inhibitors, tissues, t-lymphocytes, smoking | Chronic Obstr Pulm Dis | 2026 | 0 |
| Spatial transcriptomics reveals airway remodelling and molecular targets across COPD severity. PMID 42707927 — cells, airway remodeling, pulmonary disease, chronic obstructive, spatial transcriptomics | ERJ Open Res | 2026 | 1 |
| Genome-wide association study of asthma with high treatment burden and/or worse outcomes defined using electronic healthcare data in UK Biobank. PMID 42682922 — genes, genome-wide association study, genome, risk factors, records, therapeutics, asthma | ERJ Open Res | 2026 | 0 |
| Erratum: Generation of 3D Collagen-Embedded A549/MRC-5 Alveolar Organoids using a Mechanical Cell-Stretching Bioreactor. PMID 42615141 — cells, collagen, organoids, bioreactors | J Vis Exp | 2026 | 0 |
Clinical Studies 19
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Cohort/Consortium Investigators 8
Ongoing Clinical Trials
3 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| Canadian Consortium on Airway Mucus Occlusions in Asthma COPD and Chronic Cough NCT06858748 — chronic disease, lung, signs and symptoms, pulmonary disease, chronic obstructive, asthma, lung diseases, cough, lung diseases, obstructive, chronic cough | N/A | Recruiting | 2025 |
| The Canadian Lung Outcomes in Users of Vaping Devices Study NCT06819969 — lung, tomography, bronchoscopy, vaping, adolescent | N/A | Recruiting | 2025 |
| Using Clinical Prediction Models to Improve Treatment for Patients With Chronic Obstructive Pulmonary Disease (COPD) NCT05309356 — chronic disease, lung, insemination, artificial, heterologous, pamphlets, prescriptions, pulmonary disease, chronic obstructive, physicians, medication adherence, precision medicine, records, therapeutics, lung diseases, lung diseases, obstructive, predictive analytics | N/A | Recruiting | 2023 |
LeadR Networks
Main global connection map